Sumoylation of PPARγ contributes to vascular endothelium insulin resistance through stabilizing the PPARγ-NcoR complex

J Cell Physiol. 2019 Nov;234(11):19663-19674. doi: 10.1002/jcp.28567. Epub 2019 Apr 14.

Abstract

Sumoylation of peroxisome proliferator-activated receptor γ (PPARγ) affects its stabilization, sublocalization, and transcriptional activity. However, it remains largely unknown whether PPARγ sumoylation inhibits the transactivation effect, leading to endothelium insulin resistance (IR). To test this possibility, human umbilical vascular endothelial cells (HUVECs) with a 90% confluence were randomly allocated to two batches. One batch was first pretreated with or without vitamin E for 24 hr and the other infected with adenoviruses containing either PIAS1-shRNA (protein inhibitor of activated STAT1-short hairpin RNA) or scramble shRNA. Cells were suffered from high glucose and palmitic acid (PA) exposure for further 48 hr. The levels of PPARγ, p-IKK, IKK, and NcoR (nuclear corepressors) were measured by western blot analysis. The interaction of IKK and PIAS1, as well as the PPARγ sumoylation, were examined by coimmunoprecipitation. The results showed that the exposure of high glucose and PA induced reactive oxygen species (ROS) production and IKK activation in HUVECs, promoting the interaction of IKK and PIAS1 and the sumoylation of PPARγ. However, vitamin E and PIAS1-shRNA partially decreased ROS production and IKK activation induced by high glucose and PA exposure. These data indicate that ROS-IKK-PIAS1 pathway mediates PPARγ sumoylation, leading to endothelium IR via stabilizing PPARγ-NcoR complex. These findings benefit understanding of regulatory networks of insulin signaling, which might provide a potential target to prevent and cure IR-related diseases.

Keywords: PPARγ; ROS; endothelium; insulin resistance; sumoylation.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Endothelium, Vascular / drug effects
  • Endothelium, Vascular / metabolism
  • Gene Regulatory Networks / drug effects
  • Glucose / pharmacology
  • Human Umbilical Vein Endothelial Cells
  • Humans
  • Insulin / genetics*
  • Insulin / metabolism
  • Insulin Resistance / genetics*
  • Multiprotein Complexes / genetics
  • Nuclear Receptor Co-Repressor 1 / genetics*
  • PPAR gamma / antagonists & inhibitors
  • PPAR gamma / genetics*
  • Palmitic Acid / pharmacology
  • Protein Inhibitors of Activated STAT / genetics
  • RNA, Small Interfering / genetics
  • RNA, Small Interfering / pharmacology
  • Reactive Oxygen Species / metabolism
  • STAT1 Transcription Factor / genetics*
  • Signal Transduction / drug effects
  • Small Ubiquitin-Related Modifier Proteins / genetics
  • Sumoylation / genetics
  • Vitamin E / pharmacology

Substances

  • Insulin
  • Multiprotein Complexes
  • NCOR1 protein, human
  • Nuclear Receptor Co-Repressor 1
  • PIAS1 protein, human
  • PPAR gamma
  • PPARG protein, human
  • Protein Inhibitors of Activated STAT
  • RNA, Small Interfering
  • Reactive Oxygen Species
  • STAT1 Transcription Factor
  • Small Ubiquitin-Related Modifier Proteins
  • Vitamin E
  • Palmitic Acid
  • Glucose